Legend Biotech Corp Other Comprehensive Income Net Of Tax Exchange Differences On Translation
Legend Biotech Corp (LEGN) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of $190.40 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2026-03-10
- Legend Biotech Corp other comprehensive income net of tax exchange differences on translation for the quarter ending 2025-12-31 was $6.35M.
- Legend Biotech Corp other comprehensive income net of tax exchange differences on translation for the quarter ending 2025-09-30 was -$877.00K, a 101.42% decline year-over-year.
- Legend Biotech Corp other comprehensive income net of tax exchange differences on translation for the quarter ending 2025-06-30 was $124.20M.
- Legend Biotech Corp other comprehensive income net of tax exchange differences on translation for the quarter ending 2025-03-31 was $60.73M.
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 3 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 6 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 9 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $6.35M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $5.47M derived: sum of 2 quarters · filed 2026-03-10 | $129.67M derived: sum of 3 quarters · filed 2026-03-10 | $190.40M 20-F · filed 2026-03-10 | |
| 2025-09-30 | -$877.00K 6-K · filed 2025-11-12 | $123.32M derived: sum of 2 quarters · filed 2025-11-12 | $184.05M 6-K · filed 2025-11-12 | $68.18M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-06-30 | $124.20M 6-K · filed 2025-08-11 | $184.93M 6-K · filed 2025-08-11 | $69.06M derived: sum of 3 quarters · filed 2026-03-10 | $130.96M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2025-03-31 | $60.73M 6-K · filed 2025-05-13 | -$55.15M derived: sum of 2 quarters · filed 2026-03-10 | $6.76M derived: sum of 3 quarters · filed 2026-03-10 | -$3.78M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-12-31 | -$115.87M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$53.97M derived: sum of 2 quarters · filed 2026-03-10 | -$64.51M derived: sum of 3 quarters · filed 2026-03-10 | -$112.50M 20-F · filed 2026-03-10 | -$112.46M 20-F · filed 2025-03-11 |
| 2024-09-30 | $61.90M 6-K · filed 2025-11-12 | $51.37M derived: sum of 2 quarters · filed 2025-11-12 | $3.37M 6-K · filed 2025-11-12 | $46.68M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-06-30 | -$10.54M 6-K · filed 2025-08-11 | -$58.53M 6-K · filed 2025-08-11 | -$15.22M derived: sum of 3 quarters · filed 2026-03-10 | -$35.47M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2024-03-31 | -$47.99M 6-K · filed 2025-05-13 | -$4.69M derived: sum of 2 quarters · filed 2026-03-10 | -$24.93M derived: sum of 3 quarters · filed 2026-03-10 | -$31.90M derived: sum of 4 quarters · filed 2026-03-10 | |
| 2023-12-31 | $43.30M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $23.06M derived: sum of 2 quarters · filed 2026-03-10 | $16.09M derived: sum of 3 quarters · filed 2026-03-10 | $29.60M 20-F · filed 2026-03-10 | $29.63M 20-F · filed 2024-03-19 |
| 2023-09-30 | -$20.24M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | -$27.21M derived: sum of 2 quarters · filed 2024-11-12 | -$13.71M 6-K · filed 2024-11-12 | -$5.04M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | -$6.97M derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | $6.54M 6-K · filed 2024-08-09 | $15.20M derived: sum of 3 quarters · filed 2025-03-11 | $11.01M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | $13.51M 6-K · filed 2024-05-13 | $22.17M derived: sum of 2 quarters · filed 2025-03-11 | $17.98M derived: sum of 3 quarters · filed 2025-03-11 | ||
| 2022-12-31 | $8.66M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $4.48M derived: sum of 2 quarters · filed 2025-03-11 | $9.81M 20-F · filed 2025-03-11 | ||
| 2022-09-30 | -$4.19M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $1.14M 6-K · filed 2023-11-20 | |||
| 2022-06-30 | $5.33M 6-K · filed 2023-08-15 | ||||
| 2021-12-31 | $5.21M 20-F · filed 2024-03-19 | $10.62M 20-F · filed 2022-03-31 | |||
| 2021-06-30 | $3.31M 6-K · filed 2021-08-23 | ||||
| 2020-12-31 | $4.08M 20-F · filed 2023-03-30 | -$2.14M 20-F · filed 2021-04-02 | |||
| 2020-06-30 | -$213.00K 6-K · filed 2021-08-23 | ||||
| 2019-12-31 | -$1.27M 20-F/A · filed 2023-02-17 | $182.00K 20-F · filed 2021-04-02 | |||
| 2018-12-31 | -$1.44M 20-F · filed 2021-04-02 |